211 related articles for article (PubMed ID: 35274474)
1. Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19.
Alavizadeh SH; Doagooyan M; Zahedipour F; Torghabe SY; Baharieh B; Soleymani F; Gheybi F
IET Nanobiotechnol; 2022 May; 16(3):67-77. PubMed ID: 35274474
[TBL] [Abstract][Full Text] [Related]
2. Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections.
Asha K; Kumar P; Sanicas M; Meseko CA; Khanna M; Kumar B
J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30577479
[TBL] [Abstract][Full Text] [Related]
3. Highly Potent Antisense Oligonucleotides Locked Nucleic Acid Gapmers Targeting the SARS-CoV-2 RNA Genome.
Dauksaite V; Tas A; Wachowius F; Spruit A; van Hemert MJ; Snijder EJ; van der Veer EP; van Zonneveld AJ
Nucleic Acid Ther; 2023 Dec; 33(6):381-385. PubMed ID: 37782140
[TBL] [Abstract][Full Text] [Related]
4. Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics.
Berber B; Aydin C; Kocabas F; Guney-Esken G; Yilancioglu K; Karadag-Alpaslan M; Caliseki M; Yuce M; Demir S; Tastan C
Gene Ther; 2021 Jun; 28(6):290-305. PubMed ID: 33318646
[TBL] [Abstract][Full Text] [Related]
5. Development and application of ribonucleic acid therapy strategies against COVID-19.
Ning L; Liu M; Gou Y; Yang Y; He B; Huang J
Int J Biol Sci; 2022; 18(13):5070-5085. PubMed ID: 35982905
[TBL] [Abstract][Full Text] [Related]
6. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides targeting ORF1b block replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Dhorne-Pollet S; Fitzpatrick C; Da Costa B; Bourgon C; Eléouët JF; Meunier N; Burzio VA; Delmas B; Barrey E
Front Microbiol; 2022; 13():915202. PubMed ID: 36386681
[TBL] [Abstract][Full Text] [Related]
8. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
[TBL] [Abstract][Full Text] [Related]
9. Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5'UTR of SARS-CoV-2.
Baldassarre A; Paolini A; Bruno SP; Felli C; Tozzi AE; Masotti A
Epigenomics; 2020 Aug; 12(15):1349-1361. PubMed ID: 32875809
[TBL] [Abstract][Full Text] [Related]
10. Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets.
Kamel NA; El Wakeel LM; Aboshanab KM
Viral Immunol; 2021 Oct; 34(8):510-521. PubMed ID: 34018828
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2: a new dimension to our understanding of coronaviruses.
Araf Y; Faruqui NA; Anwar S; Hosen MJ
Int Microbiol; 2021 Jan; 24(1):19-24. PubMed ID: 33231780
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs.
Pfafenrot C; Schneider T; Müller C; Hung LH; Schreiner S; Ziebuhr J; Bindereif A
Nucleic Acids Res; 2021 Dec; 49(21):12502-12516. PubMed ID: 34850109
[TBL] [Abstract][Full Text] [Related]
13. Etiology and clinical characteristics of SARS-CoV-2 and other human coronaviruses among children in Zhejiang Province, China 2017-2019.
Zhang Y; Su L; Chen Y; Yu S; Zhang D; Mao H; Fang L
Virol J; 2021 Apr; 18(1):89. PubMed ID: 33931105
[TBL] [Abstract][Full Text] [Related]
14. Complicating Infections Associated with Common Endemic Human Respiratory Coronaviruses.
Cimolai N
Health Secur; 2021; 19(2):195-208. PubMed ID: 33186086
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
16. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.
Tarique M; Ahmad S; Malik A; Ahmad I; Saeed M; Almatroudi A; Qadah T; Murad MA; Mashraqi M; Alam Q; Al-Saleh Y
Mol Cell Biochem; 2021 May; 476(5):2203-2217. PubMed ID: 33564990
[TBL] [Abstract][Full Text] [Related]
17. Potential Drug Strategies to Target Coronaviruses.
Sarkar K; Sil PC
Adv Exp Med Biol; 2021; 1352():111-124. PubMed ID: 35132597
[TBL] [Abstract][Full Text] [Related]
18. Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2.
Wandtke T; Wędrowska E; Szczur M; Przybylski G; Libura M; Kopiński P
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163338
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence.
Tolksdorf B; Nie C; Niemeyer D; Röhrs V; Berg J; Lauster D; Adler JM; Haag R; Trimpert J; Kaufer B; Drosten C; Kurreck J
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696460
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid-based therapy for coronavirus disease 2019.
Piyush R; Rajarshi K; Chatterjee A; Khan R; Ray S
Heliyon; 2020 Sep; 6(9):e05007. PubMed ID: 32984620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
